Recordati Industria Chimica e Farmaceutica S.p.A.

Factors to consider:

• Company pays dividends (semi-annually): last record date 2026-05-19, amount 0.82$ (Y2.83%)
• Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [57.25$, 78.66$]
• 2026-12-31 to 2027-12-31 estimated range: [64.23$, 86.79$]

Financial Metrics affecting the RCDTF estimates:

• Positive: with PPE of 18.6 at the end of fiscal year the price was neutral
• Positive: 22.58 < Operating profit margin, % of 27.49
• Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 7.79
• Positive: 4.90 < Operating cash flow per share per price, % of 5.19
• Positive: 34.41 < Shareholder equity ratio, % of 36.55 <= 42.26
• Positive: 5.56 < Industry operating cash flow per share per price (median), % of 5.61
• Positive: Inventory ratio change, % of -0.69 <= -0.37
• Positive: Interest expense per share per price, % of 0.86 <= 1.42
• Positive: Industry inventory ratio change (median), % of 0.50 <= 1.15